Related Experiment Video
Updated: Jun 21, 2026

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus
Published on: March 8, 2012
Human papillomavirus and the HPV vaccine: are the benefits worth the risks?
Mary Knudtson1, Susan Tiso, Susanne Phillips
1Program in Nursing Science, Department of Nursing, University of California, Irvine, Irvine, CA 92697, USA. mdknudts@uci.edu
Abstract:
Human papillomavirus (HPV) is the most commonly sexually transmitted infection in the United States. This article gives an overview and discussion of HPV virus types and transmission, and the quadrivalent vaccine now available to protect against it. Included are the nursing implications for the HPV vaccine related to education and counseling of parents, patients, and young adult women regarding HPV vaccination, for whom the vaccine is indicated.
Related Concept Videos
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Vaccinations
Cancer Prevention
Some...
Cancer Prevention
Some...
Genital Herpes
Poliomyelitis